Abstract 7232: KDM1A/UTX Mutations Modulate Innate Immune Responses to Influence Immunotherapy Outcomes in Lung Squamous Cell Carcinoma
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-7232
Abstract: Immunotherapy has come of age for lung cancers, especially lung squamous cell carcinoma (LUSC), which lacks targeted therapies . KDM6A/UTX is frequently mutated in LUSC and is associated with poor prognosis. However, the mechanisms by… read more here.
Keywords: kdm6a utx; utx mutations; immunotherapy; lusc ... See more keywords